- Home
- NEUP vs DRCT Comparison
NEUP vs DRCT Comparison
Compare NEUP & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- DRCT
- Stock Information
- Founded
- NEUP 1996
- DRCT 2018
- Country
- NEUP United States
- DRCT United States
- Employees
- NEUP N/A
- DRCT N/A
- Industry
- NEUP
- DRCT Computer Software: Programming Data Processing
- Sector
- NEUP
- DRCT Technology
- Exchange
- NEUP Nasdaq
- DRCT Nasdaq
- Market Cap
- NEUP 12.7M
- DRCT 11.4M
- IPO Year
- NEUP N/A
- DRCT 2022
- Fundamental
- Price
- NEUP $7.20
- DRCT $0.42
- Analyst Decision
- NEUP Strong Buy
- DRCT Strong Buy
- Analyst Count
- NEUP 1
- DRCT 1
- Target Price
- NEUP $21.00
- DRCT $6.00
- AVG Volume (30 Days)
- NEUP 38.6K
- DRCT 690.0K
- Earning Date
- NEUP 08-19-2025
- DRCT 08-05-2025
- Dividend Yield
- NEUP N/A
- DRCT N/A
- EPS Growth
- NEUP N/A
- DRCT N/A
- EPS
- NEUP 0.00
- DRCT N/A
- Revenue
- NEUP $15,662,715.00
- DRCT $36,459,000.00
- Revenue This Year
- NEUP N/A
- DRCT $50.71
- Revenue Next Year
- NEUP N/A
- DRCT $26.31
- P/E Ratio
- NEUP $4,211.30
- DRCT N/A
- Revenue Growth
- NEUP N/A
- DRCT N/A
- 52 Week Low
- NEUP $2.90
- DRCT $0.39
- 52 Week High
- NEUP $126.00
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- DRCT 34.80
- Support Level
- NEUP N/A
- DRCT $0.40
- Resistance Level
- NEUP N/A
- DRCT $0.79
- Average True Range (ATR)
- NEUP 0.00
- DRCT 0.07
- MACD
- NEUP 0.00
- DRCT -0.01
- Stochastic Oscillator
- NEUP 0.00
- DRCT 8.87
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.